Second Review Aims to Improve Targeting Accuracy
When metastatic prostate cancer outpaces hormonal therapy, clinicians face a narrow set of options. Targeted alpha therapy with Actinium-225 offers ...
When metastatic prostate cancer outpaces hormonal therapy, clinicians face a narrow set of options. Targeted alpha therapy with Actinium-225 offers ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine